These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3963974)

  • 21. Requirements for publication of bioequivalence pharmacokinetic studies in Clinical Therapeutics.
    Schweers SA; Walson PD
    Clin Ther; 2009 Feb; 31(2):368-9. PubMed ID: 19302909
    [No Abstract]   [Full Text] [Related]  

  • 22. Similar, the same or just not different: a guide for deciding whether treatments are clinically equivalent. [Dept. of Medicine, Division of Cardiology, Univ. of Western Ontario, London, Ontario].
    Massel D
    Can J Cardiol; 1999 May; 15(5):556-62. PubMed ID: 10350665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Authors' reply to Comments on 'Estimation in AB/BA crossover trials with application to bioequivalence studies with incomplete and complete data designs".
    Jaki T; Pallmann P; Wolfsegger MJ
    Stat Med; 2013 Dec; 32(30):5487-8. PubMed ID: 24302284
    [No Abstract]   [Full Text] [Related]  

  • 24. Equivalence and noninferiority in anaesthesia research.
    Myles PS
    Anaesth Intensive Care; 2010 Jul; 38(4):621-2. PubMed ID: 20715723
    [No Abstract]   [Full Text] [Related]  

  • 25. Time to end the non-inferiority complex?
    Julious SA
    Pharm Stat; 2011; 10(5):393-4. PubMed ID: 21928355
    [No Abstract]   [Full Text] [Related]  

  • 26. Mandatory comparator trials for therapeutically similar drugs: an assessment of the facts.
    Milne CP; Kaitin KI; Dimasi JA
    Am J Ther; 2007; 14(3):231-4. PubMed ID: 17515695
    [No Abstract]   [Full Text] [Related]  

  • 27. On Bayesian methods for bioequivalence.
    Selwyn MR; Hall NR
    Biometrics; 1984 Dec; 40(4):1103-8. PubMed ID: 6398710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Differences in the effectiveness of levothyroxine preparations].
    Dtsch Med Wochenschr; 1988 Jul; 113(26):1081-4. PubMed ID: 3289884
    [No Abstract]   [Full Text] [Related]  

  • 29. Tests for equivalence or non-inferiority--why?
    Drug Ther Bull; 2008 Jul; 46(7):55-6. PubMed ID: 18603641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic alternatives equivalent: in the eye of the hurricane].
    López Briz E; Alegre del Rey E; Fraga Fuentes MD; Clopés Esela A; Bautista Paloma J; Ortega Eslava A;
    Farm Hosp; 2013; 37(4):273-5. PubMed ID: 24010687
    [No Abstract]   [Full Text] [Related]  

  • 31. Planning and monitoring of equivalence studies.
    Durrleman S; Simon R
    Biometrics; 1990 Jun; 46(2):329-36. PubMed ID: 2194579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Introduction to the problems of clinical pharmacological research].
    Rahlfs VW
    Int J Clin Pharmacol; 1972 Nov; 6(4):385-90. PubMed ID: 4565837
    [No Abstract]   [Full Text] [Related]  

  • 33. Half-life revisited: implication in clinical trials and bioavailability/bioequivalence evaluation.
    Chen ML; Pelsor FR
    J Pharm Sci; 1991 Apr; 80(4):406-8. PubMed ID: 1865346
    [No Abstract]   [Full Text] [Related]  

  • 34. On testing for bioequivalence.
    Rocke DM
    Biometrics; 1984 Mar; 40(1):225-30. PubMed ID: 6547355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When do differences in dissolution profiles predict clinical problems?
    Ngo SN
    J Clin Pharm Ther; 2007 Apr; 32(2):111-2. PubMed ID: 17381660
    [No Abstract]   [Full Text] [Related]  

  • 36. Tricyclic antidepressants.
    N Engl J Med; 1979 Mar; 300(9):504-6. PubMed ID: 366421
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical evaluation of the drugs and quantitative nosography].
    Robotti E; Ferrari P
    Boll Chim Farm; 1972 Sep; 111(9):531-40. PubMed ID: 4565803
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical testing of drugs].
    Elis J
    Cesk Zdrav; 1973; 21(3):126-30. PubMed ID: 4580127
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical significance of bioequivalence and interchangeability of narrow therapeutic range drugs: focus on warfarins.
    Vercaigne LM; Zhanel GG
    J Pharm Pharm Sci; 1998; 1(3):92-4. PubMed ID: 10948395
    [No Abstract]   [Full Text] [Related]  

  • 40. Practical guide to sample size calculations: non-inferiority and equivalence trials.
    Flight L; Julious SA
    Pharm Stat; 2016; 15(1):80-9. PubMed ID: 26604186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.